Genpharmasec announced a significant partnership with Amneal Healthcare Private Limited (AHPL) by entering into a Super Stockist Agreement. Under this arrangement, Amneal Healthcare will act as a non-exclusive super stockist for Genpharmasec, facilitating the distribution of pharmaceutical products to wholesale pharmacists and retail outlets across the designated territories. The agreement, effective from January 1, 2025, to December 31, 2025, includes a minimum annual sales commitment of ₹60 crore, reflecting the scale and potential of this collaboration.
Commenting on the partnership, Mr. Rajesh Sadhwani, Promoter and Director of Genpharmasec Limited, stated, “We are excited to collaborate with Amneal Healthcare, a highly respected name in the healthcare sector. This strategic agreement marks a significant step forward in our journey to expand our market presence and strengthen our distribution capabilities. By working with Amneal, we can bring an even wider range of high-quality healthcare products to our customers, ensuring greater accessibility and exceptional service standards.”
This collaboration is expected to not only enhance Genpharmasec’s operational reach but also align with its vision of sustained growth in the healthcare industry. The partnership will help both organizations leverage their respective strengths—Genpharmasec’s commitment to high-quality pharmaceutical products and Amneal Healthcare’s robust distribution network—to address the increasing demand for healthcare solutions in India.
Founded in 1992, Genpharmasec Limited has evolved from being a manufacturer and trader of chemicals and dyes to a leading name in the pharmaceutical sector. The company specializes in the distribution of niche diagnostic equipment and pharmaceutical products. Its association with global players such as Abbott Point of Care Corporation, USA, highlights its commitment to bringing advanced healthcare technologies to the Indian market.
This partnership with Amneal Healthcare underscores Genpharmasec’s commitment to innovation and customer-centric growth. By enhancing its market penetration and ensuring seamless distribution, the company is set to achieve greater milestones in the years ahead. The collaboration is also expected to create value for both parties by fostering mutual growth and delivering high-quality healthcare solutions to customers nationwide.
